DOJ, SEC end Investigations of GE HealthCare for possible FCPA violations in China

China money

The Securities and Exchange Commission (SEC) and Department of Justice (DOJ) have ended a seven-year review of GE HealthCare Technologies’ China unit for possible violations of the Foreign Corrupt Practices Act (FCPA), the company announced.

The SEC wrote a letter to the company on May 16, and the DOJ wrote on May 28, informing GE HealthCare they were closing their investigations and taking no further action, GE HealthCare, a spin-off of the General Electric Company, said.

The agencies began their investigations of the company in 2018 for its activities in certain provinces in China. 

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.